Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in Trials & Approvals

AriBio of South Korea Expands Phase III Trial of Alzheimer’s Therapy
Viatris and Theravance Report COPD Therapy Effective in China Phase III Trial
Sirius Files for Australian Trials of siRNA for Thromboembolic Disorders
Lerna Biopharma to Present New siRNA Therapy for Liver Failure
Ractigen Reveals Preclinical Results of RNA Therapy for Duchenne Muscular Dystrophy
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital